New chemo cocktail aims to shrink nasal tumors and save organs
NCT ID NCT00707473
First seen Nov 01, 2025 · Last updated Apr 25, 2026 · Updated 27 times
Summary
This study tests a combination of three chemotherapy drugs (docetaxel, cisplatin, and fluorouracil) as a first treatment for people with advanced nasal cavity or sinus cancer that hasn't spread to other parts of the body. The goal is to shrink tumors enough to avoid or reduce the need for surgery, while preserving the eye and other nearby structures. About 31 adults with stage II to IV cancer will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SINONASAL UNDIFFERENTIATED CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.